ER-β expression in large bowel adenomas: Implications in colon carcinogenesis

Digestive and Liver Disease

Volumn 40, Issue 4, 2008, Pages 260-266

  Di Leo, A ^a   Barone, M ^a   Maiorano, E ^a   Tanzi, S ^a   Piscitelli, D ^a   Marangi, S ^a   Lofano, K ^a   Ierardi, E ^b   Principi, M ^a   Francavilla, A ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Colorectal cancer; Oestrogens receptors; Polyps intestinal

Indexed keywords

CYCLINE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; COLON ADENOMA; COLON CANCER; COLON CARCINOGENESIS; COLON MUCOSA; COLON POLYP; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOSCOPIC POLYPECTOMY; FEMALE; HUMAN; HUMAN TISSUE; INTESTINE CELL; MALE; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

ADENOMA; AGED; APOPTOSIS; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; INTESTINAL NEOPLASMS; MALE; MIDDLE AGED;

EID: 39749185294     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2007.10.018     Document Type: Article

References (31)

1. Yager J.D., and Liehr J.G. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 36 (1996) 203-232
2. Fisher B., Gunduz N., Saffer E.A., and Zheng S. Relation of estrogen and its receptor to rat liver growth and regeneration. Cancer Res 44 (1984) 2410-2415
3. Francavilla A., Polimeno L., DiLeo A., Barone M., Ove P., Coetzee M., et al. The effect of estrogen and tamoxifen on hepatocyte proliferation in vivo and in vitro. Hepatology 9 (1989) 614-620
4. Messa C., Russo F., Pricci M., and Di Leo A. Epidermal growth factor and 17β-estradiol effects on proliferation of a human gastric cancer cell line (AGS). Scand J Gastroenterol 35 (2000) 753-758
5. Barone M., Ladisa R., Di Leo A., Spano D., Francioso D., Aglio V., et al. Estrogen-induced proliferation in cultured hepatocytes involves cyclin D1, p21(Cip1) and p27(Kip1). Dig Dis Sci 51 (2006) 580-586
6. Gustafsson J.A. Estrogen receptor β: a new dimension in estrogen mechanism of action. J Endocrinol 163 (1999) 379-383
7. Dechering K., Boersma C., and Mosselman S. Estrogen receptors alpha and beta: two receptors of a kind?. Current Med Chem 7 (2000) 561-576
8. Francavilla A., Di Leo A., Polimeno L., Conte D., Barone M., Fanizza G., et al. Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding non cancerous colonic tissue. Gastroenterology 93 (1987) 1301-1306
9. Linsalata M., Russo F., Cavallini A., Berloco P., and Di Leo A. Polyamines, diamine oxidase, and ornithine decarboxylase activity in colorectal cancer and in normal surrounding mucosa. Dis Colon Rectum 36 (1993) 662-667
10. Foley E.F., Jazaeri A.A., Shupnik M.A., Jazaeri O., and Rice L.W. Selective loss of estrogen receptor beta in malignant human colon. Cancer Res 60 (2000) 245-248
11. Campbell-Thompson M., Lynch I.J., and Bhardwaj B. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Res 61 (2001) 632-640
12. Weyant M.J., Carothers A.M., Mahmoud N.N., Bradlow L., Remoti H., Bilinski R.T., et al. Reciprocal expression of ERα and ERβ is associated with estrogen-mediated modulation of intestinal tumorigenesis. Cancer Res 61 (2001) 2547-2551
13. Di Leo A., Messa C., Cavallini A., and Linsalata M. Estrogens and colorectal cancer. Curr Drug Targets Immune Endocr Metabol Disord (2001) 1-12
14. Vogelstein B., Fearon E.R., Hamilton S.R., Kern S.E., Preisinger A.C., Leppert M., et al. Genetic alterations during colorectal-tumor development. N Engl J Med 319 (1988) 525-532
15. Nasir A., Kaiser H.E., Boulware D., Hakam A., Zhao H., Yeatman T., et al. Cyclooxygenase-2 expression in right- and left-sided colon cancer: a rationale for optimization of cyclooxygenase-2 inhibitor therapy. Clin Colorectal Cancer 3 (2004) 243-247
16. Konstantinopoulos P.A., Kominea A., Vandoros G., Sykiotis G.P., Andricopoulos P., Varakis I., et al. Oestrogen receptor beta (ERβ) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumor's dedifferentiation. Eur J Cancer 39 (2003) 1251-1258
17. Barone M., Berloco P., Ladisa R., Ierardi E., Caruso M.L., Valentini A.M., et al. Demonstration of a direct stimulatory effect of bile salts on rat colonic epithelial cell proliferation. Scand J Gastroenterol 37 (2002) 88-94
18. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., et al. Risk and benefit of estrogen plus progestin in health postmenopausal women: principals results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 288 (2002) 321-333
19. Nelson H., Humphrey L., Nygren P., Teutsch S., and Allan J. Postmenopausal hormone replacement therapy: a scientific review. J Am Med Assoc 288 (2002) 872-881
20. Giardiello F.M., Hylind L.M., Trimbath J.D., Hamilton S.R., Romans K.E., Cruz-Correa M., et al. Oral contraceptives and polyp regression in familial adenomatous polyposis. Gastroenterology 128 (2005) 1077-1080
21. Ierardi E., Di Leo A., Barone M., Marangi S., Burattini O., Panarese A., et al. Tumor necrosis factor alpha and apoptosis in Helicobacter pylori related progressive gastric damage a possible mechanism of immune system involvement in epithelial turnover regulation. Immunopharmacol Immunotoxical 25 (2003) 203-211
22. Barone M., Maiorano E., Ladisa R., Cuomo R., Pece A., Berloco P., et al. Influence of ursodeoxycholate-enriched diet on liver tumor growth in HBV transgenic mice. Hepatology 37 (2003) 880-886
23. Roger P., Sahla M.E., Makela S., Gustafsson J.A., Baldet P., and Rochefort H. Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res 61 (2001) 2537-2541
24. Horvath L.G., Henshall S.M., and Lee C.S. Frequent loss of estrogen receptor-beta expression in prostate cancer. Cancer Res 61 (2001) 5331-5335
25. Weihua Z., Andersson S., Cheng G., Simpson E.R., Warner M., and Gustafsson J.A. Update on estrogen signaling. FEBS Lett 546 (2003) 17-24
26. Paruthiyil S., Parmar H., Kerekatte V., Cunha G.R., Firestone G.L., and Leitman D.C. Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res 64 (2004) 423-428
27. Mahmoud N., Boolbol S., Bilinski R., Martucci C., Chadburn A., and Bertagnolli M. Apc gene mutation is associated with a dominant negative effect upon intestinal cell migration. Cancer Res 57 (1997) 5045-5050
28. Mahmoud N., Kucherlapati R., Bilinski R., Churchill M., Chadburn A., and Bertagnolli M. Genotype-phenotype correlation in murine Apc mutation: differences in enterocyte migration and response to sulindac. Cancer Res 59 (1999) 353-359
29. Javid S.H., Moran A.E., Carothers A.M., Redston M., and Bertagnolli M. Modulation of tumor formation and intestinal cell migration by estrogens in the Apc(Min/+) mouse model of colorectal cancer. Carcinogenesis 26 (2005) 587-595
30. Seidlova-Wuttke D., Becker T., Christoffel V., Jarry H., and Wuttke W. Silymarin is a selective estrogen receptor beta (ERbeta) agonist and has estrogenic effects in the metaphysis of the femur but no or antiestrogenic effects in the uterus of ovariectomized (ovx) rats. J Steroid Biochem Mol Biol 86 (2003) 179-188
31. Di Leo A., Barone M., Margiotta M., Castellaneta A., Troiani L., Demarinis L., et al. Effect of selective agonist for the estrogen receptor β (Silymarin) upon colonic cell migration in normal mice. Dig Liv Dis 38 (2006) S105